Structure-sparing resection for the management of cervical chordomas: a retrospective institutional series
- PMID: 38691869
- DOI: 10.3171/2024.2.FOCUS23710
Structure-sparing resection for the management of cervical chordomas: a retrospective institutional series
Abstract
Objective: Chordomas are a rare and relatively slow-growing malignancy of notochordal origin with a nearly 50% recurrence rate. Chordomas of the cervical spine are particularly challenging tumors given surrounding vital anatomical structures. Although standard in other areas of the spine, en bloc resection of cervical chordomas is exceedingly difficult and carries the risk of significant postoperative morbidity. Here, the authors present their institutional experience with 13 patients treated with a structure-sparing radical resection and adjuvant radiation for cervical chordomas.
Methods: Records of the standing senior author and institutional database of spinal surgeries were retrospectively reviewed for surgically managed cervical and high thoracic chordomas between 1997 and 2022. Chordomas whose epicenter was cervical but touched the clivus or had extension to the thoracic spine were included in this series. Clinical and operative data were gathered and analyzed for the index surgery and any revisions needed. Outcome metrics such as recurrence rates, complication rates, functional status, progression-free interval (PFI) and overall survival (OS) were evaluated.
Results: The median patient age at diagnosis was 57 (range 32-80) years. The median modified Rankin Scale (mRS) score at the time of presentation was 1 (range 0-4). Approximately 40% of tumors were located in the upper cervical spine (occiput-C2). The median time from diagnosis to surgery was 74.5 (range 10-483) days. Gross-total resection was achieved in just under 40% of patients. All patients received adjuvant radiotherapy. The mean duration of follow-up was 4.09 years, with a mean PFI of 3.80 (range 1.16-13.1) years. Five patients experienced recurrence (38.5%). The mean OS was 3.44 years. Three patients died during the follow-up period; 2 due to disease progression and 1 died in the immediate postoperative period. One patient was lost to follow-up. A significant positive relationship was identified between high cervical tumor location and disease recurrence (p = 0.021).
Conclusions: While en bloc resection is appropriate and feasible for tumors in the sacral spine, the cervical region poses a significant technical challenge and is associated with increased postoperative morbidity. Radical resection may allow for achievement of negative operative margins and, along with sparing postoperative morbidity following resection of cervical chordomas, maintaining a similar rate of recurrence when compared with en bloc resection while preserving quality of life.
Keywords: cervical; chordoma; en bloc resection; oncology; radical resection; spine.
Similar articles
-
En bloc resection of primary tumors of the cervical spine: report of two cases and systematic review of the literature.Spine J. 2009 Nov;9(11):928-35. doi: 10.1016/j.spinee.2009.07.005. Epub 2009 Aug 28. Spine J. 2009. PMID: 19716772
-
Multidisciplinary surgical considerations for en bloc resection of sacral chordoma: review of recent advances and a contemporary single-center series.Neurosurg Focus. 2024 May;56(5):E7. doi: 10.3171/2024.2.FOCUS23926. Neurosurg Focus. 2024. PMID: 38691863 Review.
-
Supramarginal resection of skull base chordomas: proof of concept and preliminary outcomes.Neurosurg Focus. 2024 May;56(5):E3. doi: 10.3171/2024.2.FOCUS23909. Neurosurg Focus. 2024. PMID: 38691859
-
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14. Clin Orthop Relat Res. 2023. PMID: 37314384 Free PMC article.
-
Long-term outcome of primary clival chordomas: a single-center retrospective study with an emphasis on the timing of recurrences based on the primary treatment.Neurosurg Focus. 2024 May;56(5):E4. doi: 10.3171/2024.2.FOCUS23924. Neurosurg Focus. 2024. PMID: 38691852
Cited by
-
Resection of C2 chordoma after failed ion-beam radiotherapy: illustrative case.J Neurosurg Case Lessons. 2025 Jul 28;10(4):CASE25241. doi: 10.3171/CASE25241. Print 2025 Jul 28. J Neurosurg Case Lessons. 2025. PMID: 40720900 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous